Jeremy Grantham Quest Diagnostics Inc Transaction History
Grantham, Mayo, Van Otterloo & Co. LLC
- $30.8 Billion
- Q1 2025
A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 2,006,545 shares of DGX stock, worth $275 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
2,006,545
Previous 2,268,990
11.57%
Holding current value
$275 Million
Previous $311 Million
11.57%
% of portfolio
0.89%
Previous 1.05%
Shares
26 transactions
Others Institutions Holding DGX
# of Institutions
1,067Shares Held
102MCall Options Held
468KPut Options Held
722K-
Vanguard Group Inc Valley Forge, PA13.9MShares$1.91 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.98MShares$820 Million0.12% of portfolio
-
State Street Corp Boston, MA5.18MShares$710 Million0.03% of portfolio
-
Jpmorgan Chase & CO New York, NY3.77MShares$517 Million0.04% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...